New hope for Tough-to-Treat depression? early drug trial completes
Disease control
Completed
This small, early-stage study tested a new drug called ALA-3000 in people whose depression had not improved with at least two standard treatments. The main goal was to check the drug's safety, side effects, and how it moves through the body in 37 participants. Researchers also lo…
Phase: PHASE1 • Sponsor: Alar Pharmaceuticals Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC